RU2002105016A - CONJUGATES AND METHOD FOR PRODUCING THEM, AND ALSO THEIR APPLICATION FOR THE TRANSPORT OF MOLECULES THROUGH BIOLOGICAL MEMBRANES - Google Patents
CONJUGATES AND METHOD FOR PRODUCING THEM, AND ALSO THEIR APPLICATION FOR THE TRANSPORT OF MOLECULES THROUGH BIOLOGICAL MEMBRANESInfo
- Publication number
- RU2002105016A RU2002105016A RU2002105016/15A RU2002105016A RU2002105016A RU 2002105016 A RU2002105016 A RU 2002105016A RU 2002105016/15 A RU2002105016/15 A RU 2002105016/15A RU 2002105016 A RU2002105016 A RU 2002105016A RU 2002105016 A RU2002105016 A RU 2002105016A
- Authority
- RU
- Russia
- Prior art keywords
- group
- conjugate
- molecule
- aryl residue
- cell
- Prior art date
Links
- 239000012528 membrane Substances 0.000 title claims 4
- 238000004519 manufacturing process Methods 0.000 title claims 2
- 125000003118 aryl group Chemical group 0.000 claims 23
- 210000004027 cells Anatomy 0.000 claims 10
- 125000003636 chemical group Chemical group 0.000 claims 7
- 229920000272 Oligonucleotide Polymers 0.000 claims 4
- 125000000524 functional group Chemical group 0.000 claims 3
- 229920000023 polynucleotide Polymers 0.000 claims 3
- 239000002157 polynucleotide Substances 0.000 claims 3
- 239000000126 substance Substances 0.000 claims 3
- 230000003993 interaction Effects 0.000 claims 2
- 150000003384 small molecules Chemical class 0.000 claims 2
- 229940088623 Biologically Active Substance Drugs 0.000 claims 1
- 229920002521 Macromolecule Polymers 0.000 claims 1
- NQTADLQHYWFPDB-UHFFFAOYSA-N N-hydroxy-Succinimide Chemical group ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 claims 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims 1
- 239000000654 additive Substances 0.000 claims 1
- 125000003277 amino group Chemical group 0.000 claims 1
- 230000001580 bacterial Effects 0.000 claims 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 1
- 239000000969 carrier Substances 0.000 claims 1
- 125000002668 chloroacetyl group Chemical group ClCC(=O)* 0.000 claims 1
- 238000003776 cleavage reaction Methods 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 210000003527 eukaryotic cell Anatomy 0.000 claims 1
- 150000004676 glycans Polymers 0.000 claims 1
- IQPQWNKOIGAROB-UHFFFAOYSA-N isocyanate group Chemical group [N-]=C=O IQPQWNKOIGAROB-UHFFFAOYSA-N 0.000 claims 1
- ZBKFYXZXZJPWNQ-UHFFFAOYSA-N isothiocyanate group Chemical group [N-]=C=S ZBKFYXZXZJPWNQ-UHFFFAOYSA-N 0.000 claims 1
- 210000004962 mammalian cells Anatomy 0.000 claims 1
- 239000002777 nucleoside Substances 0.000 claims 1
- 150000003833 nucleoside derivatives Chemical class 0.000 claims 1
- 229920001184 polypeptide Polymers 0.000 claims 1
- 229920001282 polysaccharide Polymers 0.000 claims 1
- 239000005017 polysaccharide Substances 0.000 claims 1
- 150000004804 polysaccharides Polymers 0.000 claims 1
- 210000001236 prokaryotic cell Anatomy 0.000 claims 1
- 125000003396 thiol group Chemical group [H]S* 0.000 claims 1
- 210000004881 tumor cells Anatomy 0.000 claims 1
- 0 CC(Oc1ccc(C=C(*=O)C(O2)=O)c2c1)=O Chemical compound CC(Oc1ccc(C=C(*=O)C(O2)=O)c2c1)=O 0.000 description 1
Claims (26)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19935302A DE19935302A1 (en) | 1999-07-28 | 1999-07-28 | Conjugates and processes for their preparation and their use for the transport of molecules across biological membranes |
DE19935302.6 | 1999-07-28 |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2002105016A true RU2002105016A (en) | 2003-11-10 |
RU2275936C2 RU2275936C2 (en) | 2006-05-10 |
Family
ID=7916258
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2002105016/15A RU2275936C2 (en) | 1999-07-28 | 2000-07-20 | Conjugates and method for their preparing and their using for transport of molecules through biological membranes |
Country Status (33)
Country | Link |
---|---|
US (1) | US8420396B2 (en) |
EP (1) | EP1204430B1 (en) |
JP (1) | JP4791665B2 (en) |
KR (1) | KR100721696B1 (en) |
CN (1) | CN1227035C (en) |
AR (1) | AR029385A1 (en) |
AT (1) | ATE447413T1 (en) |
AU (1) | AU776114B2 (en) |
BR (1) | BR0012757A (en) |
CA (1) | CA2377977C (en) |
CY (1) | CY1109744T1 (en) |
CZ (1) | CZ2002300A3 (en) |
DE (2) | DE19935302A1 (en) |
DK (1) | DK1204430T3 (en) |
EE (1) | EE05303B1 (en) |
ES (1) | ES2335741T3 (en) |
HK (1) | HK1047042A1 (en) |
HR (1) | HRP20020074B1 (en) |
HU (1) | HUP0201995A3 (en) |
IL (2) | IL147527A0 (en) |
ME (1) | MEP56408A (en) |
MX (1) | MXPA01013114A (en) |
NO (1) | NO334155B1 (en) |
NZ (1) | NZ516838A (en) |
PL (1) | PL202881B1 (en) |
PT (1) | PT1204430E (en) |
RS (2) | RS51447B (en) |
RU (1) | RU2275936C2 (en) |
SI (1) | SI1204430T1 (en) |
SK (1) | SK287654B6 (en) |
TR (4) | TR201109493T2 (en) |
WO (1) | WO2001008707A2 (en) |
ZA (1) | ZA200200657B (en) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030129251A1 (en) * | 2000-03-10 | 2003-07-10 | Gary Van Nest | Biodegradable immunomodulatory formulations and methods for use thereof |
US7026166B2 (en) * | 2002-01-22 | 2006-04-11 | Chiron Corporation | Fluorogenic dyes |
US7704756B2 (en) | 2003-01-21 | 2010-04-27 | Novartis Vaccines And Diagnostics, Inc. | Fluorogenic dyes |
ATE520784T1 (en) * | 2003-09-11 | 2011-09-15 | Universitaetsklinikum Schleswig Holstein Campus Luebeck | NUCLEOTIDE SEQUENCES PROMOTING TRANSMEMBRANT TRANSPORT OF NUCLEIC ACIDS |
US7615539B2 (en) * | 2003-09-25 | 2009-11-10 | Coley Pharmaceutical Group, Inc. | Nucleic acid-lipophilic conjugates |
EP1645288A1 (en) * | 2004-10-07 | 2006-04-12 | CTG Pharma S.r.l. | New nuclear transcription factors regulators |
KR100690199B1 (en) * | 2006-04-20 | 2007-03-12 | 이화여자대학교 산학협력단 | Fluorescein derivative having selectivity for copper ion, preparation method thereof and detection method of copper ion in vivo using the same |
KR20100068422A (en) * | 2007-10-09 | 2010-06-23 | 콜리 파마슈티칼 게엠베하 | Immune stimulatory oligonucleotide analogs containing modified sugar moieties |
BR122020024394B1 (en) * | 2010-12-29 | 2021-05-11 | F. Hoffmann-La Roche Ag | conjugate and pharmaceutical composition |
EP3151841B1 (en) * | 2014-05-23 | 2022-10-19 | Genzyme Corporation | Multiple oligonucleotide moieties on peptide carrier |
EP3493855A4 (en) * | 2016-08-02 | 2020-04-01 | ISI Life Sciences, Inc. | Compositions and methods for detecting cancer cells in a tissue sample |
US20180036312A1 (en) * | 2016-08-02 | 2018-02-08 | ISI Life Sciences Inc. | Novel Scaffolds for Intracellular Compound Delivery for the Detection of Cancer Cells |
US10753942B2 (en) | 2017-05-15 | 2020-08-25 | Indicator Systems International, Inc. | Methods to detect remnant cancer cells |
US10539567B2 (en) * | 2017-05-15 | 2020-01-21 | Indicator Systems International, Inc. | Biopsy methods and devices |
KR20230096856A (en) | 2021-12-22 | 2023-06-30 | 한국과학기술연구원 | Novel peptide-oligonucelotide conjugate and use thereof |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE8801070D0 (en) | 1988-03-23 | 1988-03-23 | Pharmacia Ab | METHOD FOR IMMOBILIZING A DNA SEQUENCE ON A SOLID SUPPORT |
WO1995006659A1 (en) * | 1992-07-01 | 1995-03-09 | Isis Pharmaceuticals, Inc. | Amine-derivatized nucleosides and oligonucleosides |
US6228982B1 (en) | 1992-05-22 | 2001-05-08 | Benget Norden | Double-stranded peptide nucleic acids |
US6335434B1 (en) | 1998-06-16 | 2002-01-01 | Isis Pharmaceuticals, Inc., | Nucleosidic and non-nucleosidic folate conjugates |
US6033909A (en) | 1992-01-22 | 2000-03-07 | Hoechst Aktiengesellschaft | Oligonucleotide analogs, their preparation and use |
NZ245720A (en) | 1992-01-22 | 1995-12-21 | Hoechst Ag | Oligonucleotide analogues; use as gene expression inhibitor or dna probe |
US5633360A (en) * | 1992-04-14 | 1997-05-27 | Gilead Sciences, Inc. | Oligonucleotide analogs capable of passive cell membrane permeation |
US5820873A (en) | 1994-09-30 | 1998-10-13 | The University Of British Columbia | Polyethylene glycol modified ceramide lipids and liposome uses thereof |
DE19502912A1 (en) | 1995-01-31 | 1996-08-01 | Hoechst Ag | G-Cap Stabilized Oligonucleotides |
US5698411A (en) | 1995-05-18 | 1997-12-16 | Coulter Corporation | Method for determining activity of enzymes in metabolically active whole cells |
AU7737196A (en) * | 1996-11-14 | 1998-06-03 | Brigham And Women's Hospital | Polyphosphoinositide binding peptides for intracellular drug delivery |
GB9809084D0 (en) | 1998-04-28 | 1998-06-24 | Nycomed Imaging As | Improvements in or relating to diagnostic/therapeutic agents |
DE19824535A1 (en) | 1998-06-03 | 1999-12-09 | Roche Diagnostics Gmbh | New rhodamine derivatives and their use |
US6335432B1 (en) | 1998-08-07 | 2002-01-01 | Bio-Red Laboratories, Inc. | Structural analogs of amine bases and nucleosides |
US6080580A (en) | 1998-10-05 | 2000-06-27 | Isis Pharmaceuticals Inc. | Antisense oligonucleotide modulation of tumor necrosis factor-α (TNF-α) expression |
AU5376500A (en) | 1999-06-17 | 2001-01-09 | Universiteit Gent | Functional poly-alpha-aminoacid derivatives useful for the modification of biologically active materials and their application |
-
1999
- 1999-07-28 DE DE19935302A patent/DE19935302A1/en not_active Ceased
-
2000
- 2000-07-20 PT PT00956220T patent/PT1204430E/en unknown
- 2000-07-20 CN CNB008091757A patent/CN1227035C/en not_active Expired - Fee Related
- 2000-07-20 MX MXPA01013114A patent/MXPA01013114A/en active IP Right Grant
- 2000-07-20 WO PCT/EP2000/006936 patent/WO2001008707A2/en active Application Filing
- 2000-07-20 DE DE50015781T patent/DE50015781D1/en not_active Expired - Lifetime
- 2000-07-20 BR BR0012757-4A patent/BR0012757A/en not_active IP Right Cessation
- 2000-07-20 HU HU0201995A patent/HUP0201995A3/en unknown
- 2000-07-20 JP JP2001513437A patent/JP4791665B2/en not_active Expired - Fee Related
- 2000-07-20 TR TR2011/09493T patent/TR201109493T2/en unknown
- 2000-07-20 TR TR2011/09491T patent/TR201109491T2/en unknown
- 2000-07-20 CA CA2377977A patent/CA2377977C/en not_active Expired - Fee Related
- 2000-07-20 SI SI200031052T patent/SI1204430T1/en unknown
- 2000-07-20 PL PL353069A patent/PL202881B1/en not_active IP Right Cessation
- 2000-07-20 SK SK117-2002A patent/SK287654B6/en not_active IP Right Cessation
- 2000-07-20 RU RU2002105016/15A patent/RU2275936C2/en not_active IP Right Cessation
- 2000-07-20 EE EEP200200035A patent/EE05303B1/en not_active IP Right Cessation
- 2000-07-20 CZ CZ2002300A patent/CZ2002300A3/en unknown
- 2000-07-20 DK DK00956220.8T patent/DK1204430T3/en active
- 2000-07-20 RS YUP-903/01A patent/RS51447B/en unknown
- 2000-07-20 IL IL14752700A patent/IL147527A0/en active IP Right Grant
- 2000-07-20 TR TR2002/00222T patent/TR200200222T2/en unknown
- 2000-07-20 TR TR2007/06709T patent/TR200706709T2/en unknown
- 2000-07-20 ES ES00956220T patent/ES2335741T3/en not_active Expired - Lifetime
- 2000-07-20 EP EP00956220A patent/EP1204430B1/en not_active Expired - Lifetime
- 2000-07-20 ME MEP-564/08A patent/MEP56408A/en unknown
- 2000-07-20 KR KR1020027001122A patent/KR100721696B1/en not_active IP Right Cessation
- 2000-07-20 AU AU68252/00A patent/AU776114B2/en not_active Ceased
- 2000-07-20 AT AT00956220T patent/ATE447413T1/en active
- 2000-07-20 NZ NZ516838A patent/NZ516838A/en not_active IP Right Cessation
- 2000-07-20 RS RSP-2010/0249A patent/RS20100249A/en unknown
- 2000-07-26 AR ARP000103870A patent/AR029385A1/en unknown
-
2002
- 2002-01-08 IL IL147527A patent/IL147527A/en not_active IP Right Cessation
- 2002-01-23 NO NO20020367A patent/NO334155B1/en not_active IP Right Cessation
- 2002-01-24 ZA ZA200200657A patent/ZA200200657B/en unknown
- 2002-01-25 HR HR20020074A patent/HRP20020074B1/en not_active IP Right Cessation
- 2002-11-29 HK HK02108623A patent/HK1047042A1/en not_active IP Right Cessation
-
2007
- 2007-01-11 US US11/622,156 patent/US8420396B2/en not_active Expired - Fee Related
-
2010
- 2010-01-20 CY CY20101100058T patent/CY1109744T1/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2002105016A (en) | CONJUGATES AND METHOD FOR PRODUCING THEM, AND ALSO THEIR APPLICATION FOR THE TRANSPORT OF MOLECULES THROUGH BIOLOGICAL MEMBRANES | |
DE69831402T2 (en) | NON-ACTING BRANCHED POLYMER CONJUGATES | |
US6552167B1 (en) | Polyamide chains of precise length | |
KR100748052B1 (en) | Hydrolytically degradable carbamate derivatives of polyethylene glycol | |
EP1198489B1 (en) | Combinations for introducing nucleic acids into cells | |
US7538192B2 (en) | Process for preparing albumin protein conjugated oligonucleotide probes | |
EP1731615A1 (en) | Cytoplasmic localization dna and rna | |
JPH08507549A (en) | Water-soluble non-immunogenic polyamide crosslinker | |
HUT71586A (en) | Process for producing lyp0philized polyalkyene oxide modified protein and polypeptide complexes with cyclodextrin | |
JPH084504B2 (en) | Stabilized superoxide dismutase | |
WO2000076550A2 (en) | Carrier-drug conjugate | |
CA2377977A1 (en) | Conjugates and methods for the production thereof, and their use for transporting molecules via biological membranes | |
US20060084149A1 (en) | Gene carriers with the use of polysaccharide and process for producing the same | |
WO2003057164A2 (en) | Compounds for delivering substances into cells | |
HU203783B (en) | Process for producing superoxide-dismutase conjugates | |
US9012594B2 (en) | Catalyst and byproduct-free native chemical ligation using cyclic thioester precursors | |
US8841408B2 (en) | Macromonomers and hydrogel systems using native chemical ligation, and their methods of preparation | |
WO1991001758A1 (en) | Biologically active drug polymer derivatives | |
MXPA01012802A (en) | Copolymers for the transfer of nucleic acids to the cell. | |
CN102935237B (en) | Adriamycin bonding medicine and preparation method thereof | |
CN107245099B (en) | Dendritic human cell penetrating peptide hPP7K, production and plasmid DNA transfection mediated method thereof | |
EP0459624B1 (en) | Galactosamine-substituted poly-omega-substituted-L-glutamic and/or-aspartic acid | |
JP2004049214A (en) | Method for introducing protein or peptide into cell | |
JPS63304000A (en) | Method for immobilizing substance derived from living body | |
Mui et al. | Preliminary crystallographic analysis of a complex between tetracycline and the trypsin-modified form of escherichia coli elongation factor tu |